UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phosphoinositide-specific phospholipase C in health and disease

Journal of lipid research, 2015-10, Vol.56 (10), p.1853-1860

2015

Volltextzugriff (PDF)

Protein kinase C involvement in cell cycle modulation

Biochemical Society transactions, 2014-10, Vol.42 (5), p.1471-1476

2014

Volltextzugriff (PDF)

Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders[S]

Journal of lipid research, 2019-02, Vol.60 (2), p.312-317

2019

Volltextzugriff (PDF)

Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-Thalassemia

International journal of molecular sciences, 2021-01, Vol.22 (2), p.827

2021

Volltextzugriff (PDF)

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes

Current pharmaceutical design, 2016-05, Vol.22 (16), p.2349-2357

2016

Volltextzugriff (PDF)

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

Current pharmaceutical design, 2016-05, Vol.22 (16), p.2358-2388

2016

Volltextzugriff (PDF)

Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia

Haematologica (Roma), 2024-08, Vol.109 (8), p.2671

2024

Volltextzugriff (PDF)

Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression

Journal of cellular physiology, 2017-09, Vol.232 (9), p.2550-2557

2017

Volltextzugriff (PDF)

Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation

Current pharmaceutical design, 2016-01, Vol.22 (16), p.2345-2348

2016

Volltextzugriff (PDF)

The physiological roles of primary phospholipase C

Advances in biological regulation, 2013-09, Vol.53 (3), p.232-241

2013

Volltextzugriff (PDF)

Phospholipase C beta1 (PI‐PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron‐induced oxidative stress in myelodysplastic syndromes (MDS)

The FASEB journal, 2020-11, Vol.34 (11), p.15400-15416

2020

Volltextzugriff (PDF)

Nuclear Phospholipids and Signaling: An Update of the Story

Cells (Basel, Switzerland), 2024-04, Vol.13 (8), p.713

2024

Volltextzugriff (PDF)

Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity

Biomolecules (Basel, Switzerland), 2024-09, Vol.14 (10), p.1243

2024

Volltextzugriff (PDF)

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Proceedings of the National Academy of Sciences - PNAS, 2009-09, Vol.106 (39), p.16811-16816

2009

Volltextzugriff (PDF)

Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology

Advances in biological regulation, 2021-01, Vol.79, p.100771-100771, Article 100771

2021

Volltextzugriff (PDF)

Primary phospholipase C and brain disorders

Advances in biological regulation, 2016-05, Vol.61, p.80-85

2016

Volltextzugriff (PDF)

Nuclear Phosphoinositides as Key Determinants of Nuclear Functions

Biomolecules (Basel, Switzerland), 2023-06, Vol.13 (7), p.1049

2023

Volltextzugriff (PDF)

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

Cells (Basel, Switzerland), 2022-07, Vol.11 (14), p.2155

2022

Volltextzugriff (PDF)

Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia

Frontiers in oncology, 2021-05, Vol.11, p.678824-678824

2021

Volltextzugriff (PDF)

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

Clinical epigenetics, 2023-02, Vol.15 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

Mini reviews in medicinal chemistry, 2014-10, Vol.14 (11), p.873-883

2014

Volltextzugriff (PDF)

PLC and PI3K/Akt/mTOR signalling in disease and cancer

Advances in biological regulation, 2015-01, Vol.57, p.10-16

2015

Volltextzugriff (PDF)

Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia

Biochimica et biophysica acta. Molecular cell research, 2020-04, Vol.1867 (4), p.118649-118649, Article 118649

2020

Volltextzugriff (PDF)

Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics

Current pharmaceutical design, 2012-05, Vol.18 (13), p.1751-1754

2012

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Humans
(63)
Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Signal Transduction
(36)
Animals
(31)
Biochemistry & Molecular Biology
(23)
Myelodysplastic Syndromes
(19)
Cell Cycle
(18)
Cell Differentiation
(18)
Myelodysplastic Syndromes - Genetics
(18)
Nucleus
(16)
Phospholipase C Beta - Genetics
(16)
Female
(15)
Phospholipase C
(15)
Phospholipase C Beta - Metabolism
(15)
Aged
(14)
Cell Nucleus - Metabolism
(14)
Gene Expression
(14)
Male
(14)
Phosphatidylinositols - Metabolism
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phosphoinositide-specific phospholipase C in health and disease

Protein kinase C involvement in cell cycle modulation

Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders[S]

Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-Thalassemia

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia

Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression

Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation

The physiological roles of primary phospholipase C

Phospholipase C beta1 (PI‐PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron‐induced oxidative stress in myelodysplastic syndromes (MDS)

Nuclear Phospholipids and Signaling: An Update of the Story

Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology

Primary phospholipase C and brain disorders

Nuclear Phosphoinositides as Key Determinants of Nuclear Functions

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

PLC and PI3K/Akt/mTOR signalling in disease and cancer

Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia

Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics

Suchergebnisse filtern